Cooler News: The State of Robotics in Grocery Markets

 

To get a clearer picture of technology innovations and solutions in robotics in the grocery delivery and fulfillment space, Cooler News tapped Joe McMenamin, Director of eCommerce at KPS Global, for some perspective.

A major reason why this conversation is relevant today is the pandemic’s disruption in the grocery industry and the increasing need for micro fulfillment centers, which have become an essential part of the grocery market equation. What does McMenamin think of the intersection between micro fulfillment centers with grocery brick and mortar stores in recent years?

“In 2019, only 3.4% of grocery sales were online,” McMenamin said. “That’s still almost $36 billion. Well, this year, it’s jumped to 10.2%, which is $106 billion. By 2025, we expect it to be 21.5% of the total market, which equates to about $250 billion. The key here is, with $250 billion, you can’t have folks walking up and down the aisles manually picking orders for online. You need to have an efficient system that’s optimized to fulfill orders quickly, and that’s where robotics is coming in.”

Because there is so much change in flux during this pandemic, many smaller grocery players are taking a wait-and-see, watch and learn approach to handling the demands of online grocery. They let the larger players experiment, figure out the best practices, and then look to adapt those processes once streamlined and affordable.
In terms of robotics, what are some of the options grocers can take advantage of today?

Some stores are choosing to create a dark store, which they can use as a mini-fulfillment center.

“Those are typically 25,000 to 80,000 square feet,” McMenamin said. “That’s the typical sizes of their grocery stores, and that’s a minimized cost option they could use. You also have micro fulfillment centers. What it does is, you may want to build into the side of the store, and you’re putting your robotics system in the market you have today, which minimizes the steps to fulfill online orders.”

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More